SSelectStock
Sign in

SUNPHARMASun Pharmaceutical

Pharma · Pharmaceuticals · NSE · as of 2026-07-19 (delayed ~30 min in market hours)

1,932.60
0.90%
79Strong

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)4,63,695.50
P/E40.45
P/B5.55
PEG1.04
ROE %14.72
ROCE %15.40
Debt / Equity0.06
EPS47.78
Revenue Growth %12.80
Profit Growth %25.10
Dividend Yield %0.83
Promoter Holding %55.61
FII Holding %28.83
DII Holding %
Beta0.08

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

Ascending TriangleLONG75%1,932.601,851.052,070.971.70
BUYConfidence 91%
  • Profit growth: 25.1% YoY
  • Debt/Equity: 0.06
  • Promoter holding: 55.6%
  • RSI: 64
  • MACD: bullish
  • Price vs EMA21: above
  • Ascending Triangle signal (confidence 75%)

Bull case

  • Profit growth: 25.1% YoY
  • Debt/Equity: 0.06
  • Promoter holding: 55.6%
  • RSI: 64

Bear case

  • Volume trend: 0.7x baseline
  • Beta: 0.08

Key risks

  • Volume trend: 0.7x baseline
  • Beta: 0.08

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹1,932.60
Stop Loss
₹1,856.81
risk 3.9%
Target 1 (1.5R)
₹2,046.29
+5.9%
Target 2 (3R)
₹2,159.97
+11.8%
Support (20d)
₹1,829.21
Resistance (52w)
₹1,962.70
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹75.79/share
ATR (volatility)
₹30.32
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹30.32). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental
75
Technical
82
Momentum
79
Risk (safety)
82

Peers — Pharma

PGHL 0.80%
83
AJANTPHARM 0.97%
81
GRANULES 2.49%
81
HESTERBIO 0.42%
80
CORONA 0.13%
80
LUPIN 1.58%
78

About

Sun Pharmaceutical operates in the Pharmaceuticals space within the Pharma sector.